The Executive Committee both manages and represents ERS by directing and conducting the general activities of the Society on behalf of the General Assembly. The Executive Committee provides an annual report on all activities to the General Assembly.
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
Irish Rugby Football Union | Ad hoc Consultancy work | A |
None
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
NovoNordisk | Unrestricted grant | D |
Fitbit | Unrestricted grant | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
Sanofi | Lecture fee | B |
Regeneron | Advisory board | B |
ALK-Abello | Lecture fee | B |
Berlin-Chemie | Lecture fee | B |
Nestle | Lecture fee | B |
None
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
Infectopharm | Clinical trial honoraria | B |
ALK-Albello | Clinical trial honoraria, advisory fee | B |
Sanofi | Clinical trial honoraria | C |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
Astra Zeneca | honoraria for lectures, consulting | B |
Chiesi | honoraria for lectures | B |
Pfizer | honoraria for lectures | B |
MSD | honoraria for lectures, consulting | B |
Takeda | honoraria for lectures | B |
Amgen | honoraria for lectures | B |
Celon Pharma | honoraria for consulting | B |
Roche Diagnostics | honoraria for lectures | B |
Grifols | honoraria for lectures, consulting | B |
CSL Behring | honoraria for lectures, consulting | B |
BMS | consulting | B |
Sanofi | honoraria for lectures, | B |
Company | Purpose and Nature of Benefit | Amount of funds received* |
---|---|---|
Astra Zeneca | congress | B |
Takeda | congress | B |
MSD | congress | B |
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
Pfizer | research grant | B |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
AstraZeneca | Ad board, consultancy | B |
GSK | Ad board, consultancy, steering committee | C |
Chiesi | Ad board, consultancy, presentation | C |
Biosency | consultancy | A |
Menarini | presentation | B |
Sanofi | ad board | C |
NOvartis | Ad board | B |
Zambon | presentation | B |
Teva | ad board | A |
Pfizer | ad board | A |
MSD | presentation | A |
ALK | presentation | B |
Company | Purpose and Nature of Benefit | Amount of funds received* |
---|---|---|
Chiesi | CPLF | A |
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
GSK | research | D |
Pfizer | research | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
DFG | Research grant | D |
Umwelt- und Nachbarschaftshaus | Research grant | D |
Umweltbundesamt | Research grant | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
Dimitris is a cystic fibrosis patient and advocate as well as Vice President of the Greek Patient Association, and founder of Patients Hub.
He won the European Lung Foundation (ELF) Award in 2021 for his efforts to ensure equal access to innovative treatments and health services for all.
Company | Area | Product | Amount of funds received* |
---|---|---|---|
boehringer ingelheim | ILD | nintedanib | A |
None
Company | Purpose and Nature of Benefit | Amount of funds received* |
---|---|---|
boeringer-ingelheim | congresses and courses | A |
medi-globe | course | A |
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
All ERS Assembly Heads are also members of the Executive Committee.